Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on September 23, 2025
KELLS Recognized as Quarterfinalist for the 2025 Digital Health Hub Foundation: Digital Health Awards
AI-powered dental benefit platform KELLS named quarterfinalist for the 2025 Digital Health Hub Awards NEW YORK, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- KELLS, the AI-powered digital dental and benefit platform, is thrilled to …
The Emerald Peek Celebrates the 100th Birthday of Beloved Resident Gloria Lehman
PEEKSKILL, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The Emerald Peek Rehabilitation and Nursing Center proudly celebrated the incredible milestone birthday of one of their most cherished residents, Mrs. Gloria Lehman, as she turned 100 …
The Albany Job Fair is Wednesday October 1st, 2025 from 9am-4pm with Veteran's Hour 9am-10am
The Albany Job Fair is Wednesday October 1st, 2025 from 9am-4pm with Veteran's Hour 9am-10am LATHAM, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The Albany Job Fair, now in its 14th year, returns Wednesday, October 1, 2025, from 9am-4pm …
BOC Sciences Joins Forces with Innovators at PODD Conference 2025
BOC Sciences is teaming up with innovators at the PODD Conference 2025 to fast-track the next generation of drug delivery. SHIRLEY, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The future of medicine rests, in large part, on effective …
ICN brings strong messages on nursing and global health workforce action to this week’s UN General Assembly
ICN’s highlights major oversight in global strategy to tackle NCDs: the global nursing and health workforce NEW YORK, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The International Council of Nurses (ICN) brings the nursing voice to this …
Persista Bio Secures Two NIH Grants to Advance O2Line™ Oxygenated Cell Therapy Platform
Funding supports large-animal studies and clinical-grade manufacturing of novel systems designed to overcome oxygenation and fibrosis barriers in cell therapy. ITHACA, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Persista Bio®, Inc. today …
Sinansys Launches Free AI to Find Vetted Alternative Suppliers and Automate RFPs
Free module identifies vetted suppliers and auto-runs RFPs—purpose-built for 2025’s tariffs, TR301 port fees, and post-de-minimis parcel disruption. NEW YORK, NY, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- Sinansys today launched its …
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement and Details of Scheme Meeting and Extraordinary General Meeting
WALTHAM, Mass. and DUBLIN, Ireland, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc, (Nasdaq: MURA) (“Mural”), a clinical-stage immuno-oncology company, today announces for the purposes of the Irish Takeover Panel Act, 1997, Takeover Rules 2022 (the …
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced the …
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September 22, 2025, the Lifecore compensation …
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company’s supplemental New Drug Application (sNDA) for the high …
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) acknowledges the decision rendered on September 23, 2025, by …
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes NANTES, France – 23 septembre 2025, 22 h 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) prend acte de la décision rendue le 23 septembre 2025 par le …
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1 …
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE: EVH). The ACO business …
Nyxoah Provides an Update on Expanded Middle East Presence
Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025 Mont-Saint-Guibert, Belgium – September 23, 2025, 10:10pm CET / 4:10pm ET – Nyxoah SA ( …
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient De nouveaux centres à Dubaï, au Koweït et à Abu Dhabi après la première implantation de Genio® dans la région au début de l'année 2025 Mont-Saint-Guibert, Belgique – 23 …
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative …